America’s obesity crisis meets the Ozempic boom as data reveals GLP-1 hot spotsAmerica’s obesity crisis meets the Ozempic boom as data reveals GLP-1 hot spots
With new agreements from President Donald Trump promising lower prices on popular weight-loss drugs, the use of GLP-1 medications such as Ozempic and Mounjaro could soon surge even higher — a trend already spreading unevenly across the U.S., with some states seeing greater uptick than others. Based on insurance claims data from Purple Lab, a Read More
Novel GLP-1 Drug on Attack Path Against Very High TriglyceridesNovel GLP-1 Drug on Attack Path Against Very High Triglycerides
(MedPage Today) — NEW ORLEANS — An investigational triple-receptor agonist made some headway in patients with severe hypertriglyceridemia, a phase II study showed. One Chinese cohort had triglycerides slashed from around 800 mg/dL at baseline… (MedPage Today) — NEW ORLEANS — An investigational triple-receptor agonist made some headway in patients with severe hypertriglyceridemia, a Read More
GLP-1 Use Prior to Pregnancy Tied to Lower Gestational Diabetes RiskGLP-1 Use Prior to Pregnancy Tied to Lower Gestational Diabetes Risk
(MedPage Today) — ATLANTA — Women who had been taking GLP-1 receptor agonist medications prior to becoming pregnant had a lower risk of gestational diabetes but not pre-eclampsia during pregnancy, according to a small retrospective cohort study… (MedPage Today) — ATLANTA — Women who had been taking GLP-1 receptor agonist medications prior to becoming Read More
Davina McCall reveals she has undergone surgery for breast cancerDavina McCall reveals she has undergone surgery for breast cancer
Presenter says she is ‘in a much more positive place’ after having lumpectomy and catching cancer earlyDavina McCall has revealed she has undergone surgery for breast cancer and urged others to “get checked”.In a video posted to Instagram, the presenter said she was “very angry” when she found out about the cancer, but felt in a “much more positive place” after a lumpectomy. Continue reading…
HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer modelHER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model
A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast cancer, according to new research published in the November issue of The Journal of Nuclear Medicine. The regimen, which pre-treats the tumor before delivering targeted alpha-radioimmunotherapy, resulted in durable major responses—including histologic cures—with minimal toxicities, paving the way for a safer and more effective treatment option for breast cancer patients.
Better Therapy, Care in Advanced Breast Cancer Has Led to Longer SurvivalBetter Therapy, Care in Advanced Breast Cancer Has Led to Longer Survival
(MedPage Today) — Patients newly diagnosed with advanced breast cancer in 2025 would be expected to live 7 months longer on average than they did 15 years ago, according to an analysis of U.S. data.
Comparing 2011-2013 to 2020-2022, the overall…
Why More Women Are Facing Breast Cancer in Pregnancy and PostpartumWhy More Women Are Facing Breast Cancer in Pregnancy and Postpartum
These cases can be difficult to find and even harder to safely treat.
Promising drug can inhibit aggressive breast cancerPromising drug can inhibit aggressive breast cancer
New research reveals a drug developed by scientists at Oregon Health & Science University may develop into a new treatment for an especially aggressive form of breast cancer.
Hopeful Lipid-Busters to Watch at AHA: New GLP-1, Gene Therapy, Oral PCSK9 InhibitorHopeful Lipid-Busters to Watch at AHA: New GLP-1, Gene Therapy, Oral PCSK9 Inhibitor
(MedPage Today) — NEW ORLEANS — Innovations in lipid lowering get a major chance to shine, and potentially move the needle in cardiometabolic treatment, this weekend here at the American Heart Association (AHA) annual meeting. Spearheading… (MedPage Today) — NEW ORLEANS — Innovations in lipid lowering get a major chance to shine, and potentially Read More
Use of Obesity Drugs in Cancer Patients Increases Despite Lack of Clinical GuidanceUse of Obesity Drugs in Cancer Patients Increases Despite Lack of Clinical Guidance
(MedPage Today) — Prescriptions for GLP-1 receptor agonists for patients with cancer have increased despite a lack of clinical guidance on the drugs’ safety and efficacy in cancer, a large retrospective review of health records showed.
Overall…